Markets:

Overview

News

Currencies

International

Treasuries

Cigna Corp (NY:CI)

283.23 +0.13 (+0.05%)

Streaming Delayed Price Updated: 2:30 PM EDT, May 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cigna Corp

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

40 41 Next >

Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth ↗

July 30, 2024

Healthcare stocks offer wealth to investors through a mix of steady performance, growth and income not to be overlooked.

Via InvestorPlace

3 Healthcare Stocks to Buy at a 52-Week Low in July ↗

July 29, 2024

At their 52-week lows, these undervalued healthcare stocks present a favorable return supported by healthcare spending tailwinds.

Via InvestorPlace

Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings ↗

July 29, 2024

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting.

Via Benzinga

Topics Economy

Don't overlook NYSE:CI—a stock with solid growth prospects and a reasonable valuation. ↗

July 23, 2024

THE CIGNA GROUP (NYSE:CI) stands out as a growth opportunity that won't break the bank.

Via Chartmill

2 Beaten-Down Dividend Stocks With Ultra-High Yields Above 9%: Are They Bargains Now? ↗

July 23, 2024

Find out if the huge yields these pressured dividend payers offer could be worth the risk.

Via The Motley Fool

Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Years ↗

July 22, 2024

Via Benzinga

For Healthy Aging, Avoid These Common Obstacles to Good Nutrition

July 22, 2024

Via StatePoint Media

If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,400 Today ↗

July 10, 2024

Via Benzinga

Looking Into Cigna Group's Recent Short Interest ↗

July 08, 2024

Via Benzinga

AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now? ↗

July 22, 2024

The big pharma company's top drug is losing ground, but its dividend keeps rising.

Via The Motley Fool

BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations ↗

July 18, 2024

Elevance Health reports Q2 revenues of $43.2 billion, slightly above consensus despite a 0.4% YoY decline driven by Medicaid membership attrition. Analysts express concerns over ongoing Medicaid margin...

Via Benzinga

Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration ↗

July 17, 2024

Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks among health insurers.

Via Benzinga

Topics Government

Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US ↗

July 11, 2024

The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical...

Via Benzinga

Topics Cannabis

Decoding Cigna Group's Options Activity: What's the Big Picture? ↗

July 05, 2024

Via Benzinga

What Analysts Are Saying About Cigna Group Stock ↗

June 26, 2024

Via Benzinga

3 of the Best Stock Buybacks So Far in 2024 ↗

July 10, 2024

S&P 500 companies made nearly $240 billion in stock buybacks in the first quarter, 9.9% higher than a year ago. Here are three of the best.

Via InvestorPlace

Topics Stocks

FTC Investigation Uncovers Anti-Competitive Practices By Handful Of Pharmacy Benefit Managers, Including CVS Health, UnitedHealth ↗

July 09, 2024

The FTC's report reveals how major PBMs like UnitedHealth, CVS, and Cigna influence drug prices, impacting small pharmacies and consumers.

Via Benzinga

When you look at NYSE:CI, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. ↗

July 08, 2024

Investors should take notice ofTHE CIGNA GROUP (NYSE:CI)—it offers a great deal for the fundamentals it presents.

Via Chartmill

Why Walgreens Boots Alliance Plunged in June ↗

July 07, 2024

Walgreens' results went from bad to worse in June.

Via The Motley Fool

Investors should take note of NYSE:CI, a growth stock that remains attractively priced. ↗

July 01, 2024

Looking for growth without the hefty price tag? Consider THE CIGNA GROUP (NYSE:CI).

Via Chartmill

Here's How Much $1000 Invested In Cigna Group 5 Years Ago Would Be Worth Today ↗

June 21, 2024

Via Benzinga

Despite its growth, NYSE:CI remains within the realm of affordability. ↗

June 10, 2024

In the world of growth stocks, NYSE:CI shines as a value proposition.

Via Chartmill

Down Over 60%, Is Walgreens Boots Alliance a Bad-News Buy? ↗

June 30, 2024

After falling a long way, the pharmacy stock is trading at a surprisingly low valuation.

Via The Motley Fool

Elevance Stock Elevated On Excellent Marketing Execution ↗

June 27, 2024

Elevance stock boasts a 92 EPS Rating out of 99. It has an 86 Composite Rating and a B+ Accumulation/Distribution Rating.

Via Investor's Business Daily

Cigna's Specialty Pharmacy Leadership Expected to Drive Long-Term EPS Growth, Analyst Says ↗

June 26, 2024

Piper Sandler has initiated coverage on Cigna, highlighting its strong position in the specialty pharmacy market and robust growth in the Cigna Healthcare and Evernorth Health Services businesses.

Via Benzinga

Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for June 2024 ↗

June 21, 2024

Commanding incredible relevancy, these strong buy healthcare stocks should be on every investor’s watch list.

Via InvestorPlace

NYSE:CI appears to be flying under the radar despite its strong fundamentals. ↗

June 17, 2024

For those who appreciate value investing, THE CIGNA GROUP (NYSE:CI) is a compelling option with its solid fundamentals.

Via Chartmill

10 Value Stocks With Low Debt And Strong Growth ↗

June 14, 2024

One of the problems we are facing as a value investor is an extremely high stock market and an aberrantly long-running bull market. It’s one of the longest in recorded history.

Via Talk Markets

Combatting the Loneliness Epidemic: The Role of Muah AI in Providing Emotional Support

June 13, 2024

Combatting the Loneliness Epidemic: The Role of Muah AI in Providing Emotional Support

Via News Direct

Topics Artificial Intelligence

AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability ↗

June 07, 2024

Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance...

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.